European Markets for Orthopedic Biomaterials

Date: November 1, 2013
Pages: 328
Price:
US$ 8,995.00
License [?]:
Publisher: iData Research Inc.
Report type: Strategic Report
Delivery: E-mail Delivery (PDF), Hard Copy Mail Delivery
ID: E2E04A8096CEN
Leaflet:

Download PDF Leaflet

European Markets for Orthopedic Biomaterials
The European orthopedic biomaterials market is expected to reach €376.7 million by 2019, with hyaluronic acid viscosupplementation as the largest segment.

The European orthopedic biomaterials market includes bone graft substitutes (BGS), hyaluronic acid (HA) viscosupplementation, bone morphogenetic protein (BMP) growth factor therapy and autologous chondrocyte implantation (ACI). As the market continued to recover from the economic crisis, slow growth was often seen across different regions. The ACI market underwent drastic changes in 2012 due to modifications in the European Medicines Agency (EMA) regulations.

While autografts were still commonly used in 2012, easy accessibility and price declines have made bone graft substitute products an attractive option. Surgeons and patients alike have become increasingly interested in minimally invasive procedures, which greatly decrease the pain associated with bone graft procedures.

Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for:
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • Sweden
  • Switzerland
  • U.K.
Report Contents:
  • Competitor Analysis
  • Identified Strategic Opportunities
  • Market Overview by Segment & Country
  • Trend Analysis by Segment & Country
  • Market Drivers & Limiters
  • Mergers & Acquisitions
  • Customer Feedback and Market Monitoring
Main Segments Included:
  • Bone Graft Substitute Market
  • Allograft Bone Graft Substitute Market
  • Synthetic Bone Graft Substitute Market
  • Demineralized Bone Matrix Bone Graft Substitute Market
  • Hyaluronic Acid Viscosupplementation Market
  • Bone Morphogenetic Protein Growth Factor Market
  • Autologous Chondrocyte Implantation Market
Sub-Segments Included:
  • Allograft Cervical Spine Market
  • Allograft Thoracolumbar Spine Market
  • Allograft Trauma and Reconstruction Market
  • Allograft Craniomaxillofacial Market
  • Synthetic Cervical Spine Market
  • Synthetic Thoracolumbar Spine Market
  • Synthetic Trauma and Reconstruction Market
  • Synthetic Craniomaxillofacial Market
  • Cervical Spine Demineralized Bone Matrix Market
  • Thoracolumbar Spine Demineralized Bone Matrix Market
  • Trauma and Reconstruction Demineralized Bone Matrix Market
  • Craniomaxillofacial Demineralized Bone Matrix Market
Companies Included:
  • DePuy SynthesOlympus
  • Zimmer
  • Wright Medical
  • Smith & Nephew
  • RottaPharm
  • Fidia
  • Genzyme
  • Medtronic
  • TRB Chemedica
  • Laboratoire Genevrier
  • Stryker
  • RTI Biologics
  • Biomet
  • Croma-Pharma
  • TiGenix
  • Fin-Ceramica
  • Tedec-Meiji
  • Seikagaku
Others include: Anika, Bioiberica, Biocomposites Ltd, Biomatlante, Biomet, Curasan, Documedica, Exactech, Ferring, Geistlich, Integra Biologics, Kuros, LCA Pharmaceuticals, Ortotech, Plasmaconcept AG, Recordati, Scient’x-Alphatec Spine, Stella Pharmaceuticals.
EXECUTIVE SUMMARY

1.1 TOTAL EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET
1.2 BONE GRAFT SUBSTITUTE MARKET
1.3 ALLOGRAFT BONE GRAFT SUBSTITUTE MARKET
1.4 SYNTHETIC BONE GRAFT SUBSTITUTE MARKET
1.5 DEMINERALIZED BONE MATRIX BONE GRAFT SUBSTITUTE MARKET
1.6 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
1.7 BONE MORPHOGENETIC PROTEIN GROWTH FACTOR MARKET
1.8 AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET
1.9 COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY

2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
  Step 1: Project Initiation & Team Selection
  Step 2: Prepare Data Systems and Perform Secondary Research
  Step 3: Preparation for Interviews & Questionnaire Design
  Step 4: Performing Primary Research
  Step 5: Research Analysis: Establishing Baseline Estimates
  Step 6: Market Forecast and Analysis
  Step 7: Identify Strategic Opportunities
  Step 8: Final Review and Market Release
  Step 9: Customer Feedback and Market Monitoring

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET

3.1 INTRODUCTION
  3.1.1 Products
    3.1.1.1 Growth Factors
    3.1.1.2 Bone Graft Substitutes
    3.1.1.3 Hyaluronic Acid Viscosupplementation
    3.1.1.4 Autologous Chondrocyte Implantation
3.2 CURRENCY EXCHANGE RATE
3.3 MARKET OVERVIEW
3.4 TREND ANALYSIS
3.5 DRIVERS AND LIMITERS
  3.5.1 Market Drivers
  3.5.2 Market Limiters
3.6 COMPETITIVE ANALYSIS
3.7 MARKET CONCENTRATION
3.8 MERGERS AND ACQUISITIONS

COUNTRY PROFILES

4.1 INTRODUCTION
  4.1.1 Population
  4.1.2 GDP per Capita
  4.1.3 Procedures
  4.1.4 Price Index
4.2 GERMANY
4.3 FRANCE
4.4 UNITED KINGDOM
4.5 SPAIN
4.6 ITALY
4.7 BENELUX
4.8 SCANDINAVIA
4.9 SWITZERLAND
4.10 AUSTRIA
4.11 PORTUGAL

BONE GRAFT SUBSTITUTE MARKET

5.1 INTRODUCTION
  5.1.1 Volumes Represented per Procedure
5.2 MARKET OVERVIEW
  5.2.1 Bone Graft Substitute Market by Indication
  5.2.2 Bone Graft Substitute Market by Segment
5.3 MARKET ANALYSIS AND FORECAST
  5.3.1 Total Bone Graft Substitute Market
  5.3.2 Total Allograft Market
    5.3.2.1 Total Allograft Spine Market
      5.3.2.1.1 Allograft Cervical Spine Market
      5.3.2.1.2 Allograft Thoracolumbar Spine Market
      5.3.2.1.3 Allograft Trauma and Reconstruction Market
    5.3.2.2 Allograft Craniomaxillofacial Market
  5.3.3 Total Synthetic Market
    5.3.3.1 Total Synthetic Spine Market
    5.3.3.2 Synthetic Cervical Spine Market
    5.3.3.3 Synthetic Thoracolumbar Spine Market
    5.3.3.4 Synthetic Trauma and Reconstruction Market
    5.3.3.5 Synthetic Craniomaxillofacial Market
  5.3.4 Total Demineralized Bone Matrix Market
    5.3.4.1 Total Spine Demineralized Bone Matrix Market
    5.3.4.2 Cervical Spine Demineralized Bone Matrix Market
    5.3.4.3 Thoracolumbar Spine Demineralized Bone Matrix Market
    5.3.4.4 Trauma and Reconstruction Demineralized Bone Matrix Market
    5.3.4.5 Craniomaxillofacial Demineralized Bone Matrix Market
5.4 DRIVERS AND LIMITERS
  5.4.1 Market Drivers
  5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

6.1 INTRODUCTION
6.2 MARKET OVERVIEW
6.3 MARKET ANALYSIS AND FORECAST
  6.3.1 Total Hyaluronic Acid Viscosupplementation Market
  6.3.2 Single-Injection Market
    6.3.2.1 Three-Injection Market
    6.3.2.2 Five-Injection Market
6.4 DRIVERS AND LIMITERS
  6.4.1 Market Drivers
  6.4.2 Market Limiters
6.5 COMPETITIVE ANALYSIS

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET

7.1 INTRODUCTION
7.2 MARKET ANALYSIS AND FORECAST
7.3 MARKET DRIVERS AND LIMITERS
  7.3.1 Market Drivers
  7.3.2 Market Limiters
7.4 COMPETITIVE ANALYSIS

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

8.1 INTRODUCTION
  8.1.1 Regulations and Legislation
8.2 MARKET ANALYSIS AND FORECAST
8.3 DRIVERS AND LIMITERS
  8.3.1 Market Drivers
  8.3.2 Market Limiters
8.4 COMPETITIVE ANALYSIS

ABBREVIATIONS
Skip to top


Ask Your Question

European Markets for Orthopedic Biomaterials
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: